GB9715298D0 - Novel method of treatment - Google Patents

Novel method of treatment

Info

Publication number: GB9715298D0
Authority: GB; United Kingdom
Prior art keywords: treatment; novel method; novel
Prior art date: 1997-07-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB9715298A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-18

Filing date

1997-07-18

Publication date

1997-09-24

1997-07-18 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

1997-07-18 Priority to GB9715298A priority Critical patent/GB9715298D0/en

1997-09-24 Publication of GB9715298D0 publication Critical patent/GB9715298D0/en

1998-07-15 Priority to DZ980173A priority patent/DZ2563A1/en

1998-07-16 Priority to MA25172A priority patent/MA24608A1/en

1998-07-16 Priority to JP2000502777A priority patent/JP2001510160A/en

1998-07-16 Priority to EA200000140A priority patent/EA200000140A1/en

1998-07-16 Priority to PL98338140A priority patent/PL338140A1/en

1998-07-16 Priority to CN98807147A priority patent/CN1263467A/en

1998-07-16 Priority to IDW20000077A priority patent/ID23804A/en

1998-07-16 Priority to PE1998000630A priority patent/PE99499A1/en

1998-07-16 Priority to CA002297133A priority patent/CA2297133A1/en

1998-07-16 Priority to KR1020007000517A priority patent/KR20010021952A/en

1998-07-16 Priority to ARP980103482A priority patent/AR016350A1/en

1998-07-16 Priority to IL13390798A priority patent/IL133907A0/en

1998-07-16 Priority to AU84490/98A priority patent/AU8449098A/en

1998-07-16 Priority to SK61-2000A priority patent/SK612000A3/en

1998-07-16 Priority to EP98935129A priority patent/EP1001784A1/en

1998-07-16 Priority to PCT/GB1998/002112 priority patent/WO1999003478A1/en

1998-07-16 Priority to TR2000/00133T priority patent/TR200000133T2/en

1998-07-16 Priority to BR9810292-3A priority patent/BR9810292A/en

1998-07-16 Priority to HU0003626A priority patent/HUP0003626A3/en

1998-07-17 Priority to CO98040749A priority patent/CO4940489A1/en

1998-07-17 Priority to ZA9806364A priority patent/ZA986364B/en

1998-07-17 Priority to UY25101A priority patent/UY25101A1/en

1999-06-28 Priority to ARP990103110A priority patent/AR019724A2/en

2000-01-06 Priority to BG104062A priority patent/BG104062A/en

2000-01-14 Priority to APAP/P/2000/001735A priority patent/AP2000001735A0/en

2000-01-17 Priority to NO20000230A priority patent/NO20000230D0/en

2000-01-18 Priority to OA1200000013A priority patent/OA11312A/en

2001-11-20 Priority to US09/989,572 priority patent/US20020052324A1/en

2002-12-18 Priority to US10/322,982 priority patent/US20030092750A1/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

GB9715298A 1997-07-18 1997-07-18 Novel method of treatment Pending GB9715298D0 (en)

Priority Applications (30)

Application Number	Priority Date	Filing Date	Title
GB9715298A GB9715298D0 (en)	1997-07-18	1997-07-18	Novel method of treatment
DZ980173A DZ2563A1 (en)	1997-07-18	1998-07-15	Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycerinic biguanide alpha-glucosidase inhibitor.
HU0003626A HUP0003626A3 (en)	1997-07-18	1998-07-16	Pharmaceutical composition for treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
SK61-2000A SK612000A3 (en)	1997-07-18	1998-07-16	Application of insulin sensitiser, insulin secretagogue and alpha glucosidase inhibitor antihyperglycaemic agent for the treatment of diabetes mellitus and conditions associated with diabetes mellitus and a pharmaceutical composition
TR2000/00133T TR200000133T2 (en)	1997-07-18	1998-07-16	Treatment of diabetes (diabetic) with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor.
EA200000140A EA200000140A1 (en)	1997-07-18	1998-07-16	METHOD FOR TREATING DIABETES THIAZOLIDINDIONE, A MEANS FOR STRENGTHENING INSULIN SECRETION, AND ALPHA-GLUCOSIDASE INHIBITOR
PL98338140A PL338140A1 (en)	1997-07-18	1998-07-16	Method of treating diebetes by means of derivatives of thiazolydinone, of insulin secretion stimulating agent and of alpha-glucosidase inhibitor
CN98807147A CN1263467A (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
IDW20000077A ID23804A (en)	1997-07-18	1998-07-16	DIABETES MANAGEMENT WITH TIAZOLIDINDION INSULIN SECRETAGOG AND ALFA GLUCOSIDASE OBLIGATORS
PE1998000630A PE99499A1 (en)	1997-07-18	1998-07-16	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
CA002297133A CA2297133A1 (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
KR1020007000517A KR20010021952A (en)	1997-07-18	1998-07-16	Treatment of Diabetes with Thiazolidinedione, Insulin Secretagogue and Alpha Glucocidase Inhibitor
ARP980103482A AR016350A1 (en)	1997-07-18	1998-07-16	USE OF AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALFA-GLUCOSIDASE INHIBITING ANTI-HERITAGE AGENT TO PREPARE MEDICATIONS
IL13390798A IL133907A0 (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AU84490/98A AU8449098A (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
MA25172A MA24608A1 (en)	1997-07-18	1998-07-16	COMPOSITIONS CONTAINING AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALPHAT-GLUGOSIDASE INHIBITOR ANTI-HEPERGLYCEMIC AGENT.
EP98935129A EP1001784A1 (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
PCT/GB1998/002112 WO1999003478A1 (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
JP2000502777A JP2001510160A (en)	1997-07-18	1998-07-16	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha-glucosidase inhibitor
BR9810292-3A BR9810292A (en)	1997-07-18	1998-07-16	Diabetes treatment with thiazolidinedione, insulin secretagogue and alpha-glucosidase inhibitor
UY25101A UY25101A1 (en)	1997-07-18	1998-07-17	METHOD FOR THE TREATMENT OF DIABETES MELLITUS AND ASSOCIATED CONDITIONS
CO98040749A CO4940489A1 (en)	1997-07-18	1998-07-17	NEW METHOD OF TREATMENT CINEMA ASSOCIATED WITH THE SAME IN MAMMALS
ZA9806364A ZA986364B (en)	1997-07-18	1998-07-17	Novel method of treatment.
ARP990103110A AR019724A2 (en)	1997-07-18	1999-06-28	PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF MELLITUS DIABETES AND ASSOCIATED CONDITIONS
BG104062A BG104062A (en)	1997-07-18	2000-01-06	Treatment of diabetes with thiazolidindion, stimulant of insulin secretion and alpha-glucosidase inhibitor
APAP/P/2000/001735A AP2000001735A0 (en)	1997-07-18	2000-01-14	Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
NO20000230A NO20000230D0 (en)	1997-07-18	2000-01-17	Treatment of diabetes with thiazolidinedione, insulin secretagogue and <alfa> glucosidase inhibitor
OA1200000013A OA11312A (en)	1997-07-18	2000-01-18	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor.
US09/989,572 US20020052324A1 (en)	1997-07-18	2001-11-20	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US10/322,982 US20030092750A1 (en)	1997-07-18	2002-12-18	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9715298A GB9715298D0 (en)	1997-07-18	1997-07-18	Novel method of treatment

Publications (1)

Publication Number	Publication Date
GB9715298D0 true GB9715298D0 (en)	1997-09-24

Family

ID=10816170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB9715298A Pending GB9715298D0 (en)	1997-07-18	1997-07-18	Novel method of treatment

Country Status (27)

Country	Link
EP (1)	EP1001784A1 (en)
JP (1)	JP2001510160A (en)
KR (1)	KR20010021952A (en)
CN (1)	CN1263467A (en)
AP (1)	AP2000001735A0 (en)
AR (2)	AR016350A1 (en)
AU (1)	AU8449098A (en)
BG (1)	BG104062A (en)
BR (1)	BR9810292A (en)
CA (1)	CA2297133A1 (en)
CO (1)	CO4940489A1 (en)
DZ (1)	DZ2563A1 (en)
EA (1)	EA200000140A1 (en)
GB (1)	GB9715298D0 (en)
HU (1)	HUP0003626A3 (en)
ID (1)	ID23804A (en)
IL (1)	IL133907A0 (en)
MA (1)	MA24608A1 (en)
NO (1)	NO20000230D0 (en)
OA (1)	OA11312A (en)
PE (1)	PE99499A1 (en)
PL (1)	PL338140A1 (en)
SK (1)	SK612000A3 (en)
TR (1)	TR200000133T2 (en)
UY (1)	UY25101A1 (en)
WO (1)	WO1999003478A1 (en)
ZA (1)	ZA986364B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
EP1849475A1 (en)	1999-06-21	2007-10-31	Eli Lilly & Company	Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
ES2433476T3 (en) *	2000-01-21	2013-12-11	Novartis Ag	Combinations containing dipeptidylpeptidase-IV inhibitors and antidiabetic agents
JP4917712B2 (en) *	2000-02-24	2012-04-18	武田薬品工業株式会社	Concomitant medication
CA2401356A1 (en) *	2000-02-24	2001-08-30	Takeda Chemical Industries, Ltd.	Combination drug
EP1349531A1 (en)	2001-01-12	2003-10-08	Sun Pharmaceuticals Industries Ltd.	Spaced drug delivery system
FR2832930A1 (en) *	2001-12-03	2003-06-06	Lipha	PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
TWI339586B (en)	2003-10-31	2011-04-01	Takeda Chemical Industries Ltd	Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) *	2006-07-14	2011-03-30	北京华安佛医药研究中心有限公司	Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0601001B1 (en) *	1991-08-26	1997-04-16	PHARMACIA & UPJOHN COMPANY	Liquid food product containing 3-guanidinopropionic acid
US5917052A (en) *	1994-09-28	1999-06-29	Shaman Pharmaceuticals, Inc.	Hypoglycemic agent from cryptolepis
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1997
- 1997-07-18 GB GB9715298A patent/GB9715298D0/en active Pending
1998
- 1998-07-15 DZ DZ980173A patent/DZ2563A1/en active
- 1998-07-16 WO PCT/GB1998/002112 patent/WO1999003478A1/en not_active Application Discontinuation
- 1998-07-16 HU HU0003626A patent/HUP0003626A3/en unknown
- 1998-07-16 EP EP98935129A patent/EP1001784A1/en not_active Withdrawn
- 1998-07-16 SK SK61-2000A patent/SK612000A3/en unknown
- 1998-07-16 PE PE1998000630A patent/PE99499A1/en not_active Application Discontinuation
- 1998-07-16 AU AU84490/98A patent/AU8449098A/en not_active Abandoned
- 1998-07-16 CA CA002297133A patent/CA2297133A1/en not_active Abandoned
- 1998-07-16 BR BR9810292-3A patent/BR9810292A/en not_active IP Right Cessation
- 1998-07-16 IL IL13390798A patent/IL133907A0/en unknown
- 1998-07-16 EA EA200000140A patent/EA200000140A1/en unknown
- 1998-07-16 AR ARP980103482A patent/AR016350A1/en unknown
- 1998-07-16 MA MA25172A patent/MA24608A1/en unknown
- 1998-07-16 TR TR2000/00133T patent/TR200000133T2/en unknown
- 1998-07-16 JP JP2000502777A patent/JP2001510160A/en active Pending
- 1998-07-16 PL PL98338140A patent/PL338140A1/en unknown
- 1998-07-16 CN CN98807147A patent/CN1263467A/en active Pending
- 1998-07-16 ID IDW20000077A patent/ID23804A/en unknown
- 1998-07-16 KR KR1020007000517A patent/KR20010021952A/en not_active Withdrawn
- 1998-07-17 CO CO98040749A patent/CO4940489A1/en unknown
- 1998-07-17 UY UY25101A patent/UY25101A1/en not_active Application Discontinuation
- 1998-07-17 ZA ZA9806364A patent/ZA986364B/en unknown
1999
- 1999-06-28 AR ARP990103110A patent/AR019724A2/en unknown
2000
- 2000-01-06 BG BG104062A patent/BG104062A/en unknown
- 2000-01-14 AP APAP/P/2000/001735A patent/AP2000001735A0/en unknown
- 2000-01-17 NO NO20000230A patent/NO20000230D0/en not_active Application Discontinuation
- 2000-01-18 OA OA1200000013A patent/OA11312A/en unknown

Also Published As

Publication number	Publication date
AR016350A1 (en)	2001-07-04
DZ2563A1 (en)	2003-02-15
SK612000A3 (en)	2000-07-11
BR9810292A (en)	2000-09-19
JP2001510160A (en)	2001-07-31
NO20000230L (en)	2000-01-17
CO4940489A1 (en)	2000-07-24
OA11312A (en)	2003-10-24
HUP0003626A3 (en)	2001-12-28
NO20000230D0 (en)	2000-01-17
ZA986364B (en)	2000-01-17
TR200000133T2 (en)	2000-09-21
AR019724A2 (en)	2002-03-13
EA200000140A1 (en)	2000-06-26
EP1001784A1 (en)	2000-05-24
KR20010021952A (en)	2001-03-15
BG104062A (en)	2000-11-30
UY25101A1 (en)	2000-12-29
ID23804A (en)	2000-05-11
CN1263467A (en)	2000-08-16
WO1999003478A1 (en)	1999-01-28
IL133907A0 (en)	2001-04-30
AU8449098A (en)	1999-02-10
PE99499A1 (en)	1999-12-18
CA2297133A1 (en)	1999-01-28
HUP0003626A2 (en)	2001-05-28
AP2000001735A0 (en)	2000-01-16
PL338140A1 (en)	2000-09-25
MA24608A1 (en)	1999-04-01

Publication	Publication Date	Title
ZA977564B (en)	1999-02-22	Method of treatment
GB9715295D0 (en)	1997-09-24	Novel method of treatment
GB9712866D0 (en)	1997-08-20	Novel method of treatment
GB9707693D0 (en)	1997-06-04	Novel method of treatment
GB9715298D0 (en)	1997-09-24	Novel method of treatment
GB9715306D0 (en)	1997-09-24	Novel method of treatment
ZA973988B (en)	1998-11-09	Method of treatment
GB9618341D0 (en)	1996-10-16	Method of treatment
PL345261A1 (en)	2001-12-03	Method of treatment
PL349421A1 (en)	2002-07-29	Novel method of treatment
GB9415902D0 (en)	1994-09-28	Method of treatment
EG24199A (en)	2008-10-19	Novel method of treatment
EG24157A (en)	2008-08-20	Novel method of treatment
GB9407335D0 (en)	1994-06-08	Method of treatment
GB9712865D0 (en)	1997-08-20	Novel method of treatment
GB9717399D0 (en)	1997-10-22	Method of treatment
GB9724289D0 (en)	1998-01-14	Method of treatment
EG24158A (en)	2008-08-20	Novel method of treatment
GB9822681D0 (en)	1998-12-09	Method of treatment
GB9414652D0 (en)	1994-09-07	Method of treatment
GB9701448D0 (en)	1997-03-12	Methods of treatment
GB9824789D0 (en)	1999-01-06	Novel method of treatment
GB9824871D0 (en)	1999-01-06	Novel method of treatment
GB9824790D0 (en)	1999-01-06	Novel method of treatment
SI1135128T1 (en)	2007-12-31	Novel method of treatment